ARIAD Pharma (ARIA) Updates on Amended 13D from Sarissa Capital; Certain Members Bought $8.8M of Conv. Notes
Tweet Send to a Friend
As previously disclosed, on October 31, 2013, ARIAD Pharma (Nasdaq: ARIA) entered into a Section 382 Rights Agreement (the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
